JP2015037579A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015037579A5 JP2015037579A5 JP2014203550A JP2014203550A JP2015037579A5 JP 2015037579 A5 JP2015037579 A5 JP 2015037579A5 JP 2014203550 A JP2014203550 A JP 2014203550A JP 2014203550 A JP2014203550 A JP 2014203550A JP 2015037579 A5 JP2015037579 A5 JP 2015037579A5
- Authority
- JP
- Japan
- Prior art keywords
- pressure
- command module
- patient
- time
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000009423 ventilation Methods 0.000 claims description 144
- 239000007789 gas Substances 0.000 claims description 89
- 210000004072 Lung Anatomy 0.000 claims description 81
- 230000002269 spontaneous Effects 0.000 claims description 65
- 229910052760 oxygen Inorganic materials 0.000 claims description 51
- 239000001301 oxygen Substances 0.000 claims description 50
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 50
- 230000035565 breathing frequency Effects 0.000 claims description 38
- 238000004891 communication Methods 0.000 claims description 19
- 230000003434 inspiratory Effects 0.000 claims description 15
- 230000003247 decreasing Effects 0.000 claims description 10
- 230000000737 periodic Effects 0.000 claims description 9
- 208000000884 Airway Obstruction Diseases 0.000 claims description 8
- 208000008784 Apnea Diseases 0.000 claims description 8
- 206010002974 Apnoea Diseases 0.000 claims description 8
- 206010043089 Tachypnoea Diseases 0.000 claims description 8
- 230000036391 respiratory frequency Effects 0.000 claims description 8
- 238000005070 sampling Methods 0.000 claims description 7
- 230000004202 respiratory function Effects 0.000 claims description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 66
- 230000002829 reduced Effects 0.000 description 26
- 230000001976 improved Effects 0.000 description 22
- 230000004044 response Effects 0.000 description 19
- 238000000034 method Methods 0.000 description 15
- 230000002685 pulmonary Effects 0.000 description 12
- 206010069351 Acute lung injury Diseases 0.000 description 11
- 208000004852 Lung Injury Diseases 0.000 description 11
- 241001594857 Pao Species 0.000 description 11
- 206010069363 Traumatic lung injury Diseases 0.000 description 11
- 231100000515 lung injury Toxicity 0.000 description 11
- 230000000241 respiratory Effects 0.000 description 11
- 230000001276 controlling effect Effects 0.000 description 10
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 9
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 9
- 210000004369 Blood Anatomy 0.000 description 8
- 208000010285 Ventilator-Induced Lung Injury Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 238000005399 mechanical ventilation Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 206010020591 Hypercapnia Diseases 0.000 description 7
- 206010029315 Neuromuscular blockade Diseases 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000006011 modification reaction Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 206010039897 Sedation Diseases 0.000 description 6
- 230000000977 initiatory Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000036280 sedation Effects 0.000 description 6
- 230000004083 survival Effects 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000003750 conditioning Effects 0.000 description 5
- 230000036961 partial Effects 0.000 description 5
- 230000006399 behavior Effects 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000000670 limiting Effects 0.000 description 4
- 239000000842 neuromuscular blocking agent Substances 0.000 description 4
- 238000003325 tomography Methods 0.000 description 4
- 206010002855 Anxiety Diseases 0.000 description 3
- 206010057666 Anxiety disease Diseases 0.000 description 3
- 206010003598 Atelectasis Diseases 0.000 description 3
- 206010021133 Hypoventilation Diseases 0.000 description 3
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 3
- 206010038687 Respiratory distress Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000000004 hemodynamic Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 230000035812 respiration Effects 0.000 description 3
- 230000001624 sedative Effects 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 238000003339 Best practice Methods 0.000 description 2
- 206010020952 Hypocapnia Diseases 0.000 description 2
- 206010022114 Injury Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000005333 Pulmonary Edema Diseases 0.000 description 2
- 206010037423 Pulmonary oedema Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 230000002354 daily Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002349 favourable Effects 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 230000004199 lung function Effects 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000002093 peripheral Effects 0.000 description 2
- 230000002035 prolonged Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 201000004193 respiratory failure Diseases 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000002104 routine Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003068 static Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 230000003519 ventilatory Effects 0.000 description 2
- 206010000364 Accessory muscle Diseases 0.000 description 1
- 206010001053 Acute respiratory failure Diseases 0.000 description 1
- 206010061688 Barotrauma Diseases 0.000 description 1
- 230000035639 Blood Levels Effects 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 210000000624 Ear Auricle Anatomy 0.000 description 1
- 210000003811 Fingers Anatomy 0.000 description 1
- 208000008745 Healthcare-Associated Pneumonia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 208000009856 Lung Disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 210000001147 Pulmonary Artery Anatomy 0.000 description 1
- 208000008203 Tachypnea Diseases 0.000 description 1
- 210000003371 Toes Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002051 biphasic Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000002612 cardiopulmonary Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000002596 correlated Effects 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000001595 flow curve Methods 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000297 inotrophic Effects 0.000 description 1
- -1 inotropics Substances 0.000 description 1
- 230000002452 interceptive Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 230000000116 mitigating Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000003252 repetitive Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000002459 sustained Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000001052 transient Effects 0.000 description 1
- 230000001960 triggered Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000000033 vasopressor Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92483507P | 2007-06-01 | 2007-06-01 | |
| US60/924,835 | 2007-06-01 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510561A Division JP5628669B2 (ja) | 2007-06-01 | 2008-06-02 | 換気のための人口呼吸器の装置およびシステム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015037579A JP2015037579A (ja) | 2015-02-26 |
| JP2015037579A5 true JP2015037579A5 (fr) | 2015-04-09 |
| JP6001029B2 JP6001029B2 (ja) | 2016-10-05 |
Family
ID=39720088
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510561A Active JP5628669B2 (ja) | 2007-06-01 | 2008-06-02 | 換気のための人口呼吸器の装置およびシステム |
| JP2014203550A Active JP6001029B2 (ja) | 2007-06-01 | 2014-10-02 | 換気のための人口呼吸器の装置およびシステム |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510561A Active JP5628669B2 (ja) | 2007-06-01 | 2008-06-02 | 換気のための人口呼吸器の装置およびシステム |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2167178A1 (fr) |
| JP (2) | JP5628669B2 (fr) |
| CA (2) | CA2726604C (fr) |
| WO (1) | WO2008148134A1 (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5915379A (en) | 1997-03-14 | 1999-06-29 | Nellcor Puritan Bennett Incorporated | Graphic user interface for a patient ventilator |
| US8021310B2 (en) | 2006-04-21 | 2011-09-20 | Nellcor Puritan Bennett Llc | Work of breathing display for a ventilation system |
| US7784461B2 (en) | 2006-09-26 | 2010-08-31 | Nellcor Puritan Bennett Llc | Three-dimensional waveform display for a breathing assistance system |
| US20080295839A1 (en) * | 2007-06-01 | 2008-12-04 | Habashi Nader M | Ventilator Apparatus and System of Ventilation |
| WO2009120639A2 (fr) * | 2008-03-27 | 2009-10-01 | Nellcor Puritan Bennett Llc | Systèmes d'assistance respiratoire avec manœuvres de recrutement pulmonaire |
| WO2010067224A1 (fr) * | 2008-12-10 | 2010-06-17 | Koninklijke Philips Electronics, N.V. | Ventilation à deux niveaux de pression dans les voies aériennes (aprv) |
| US20100224191A1 (en) * | 2009-03-06 | 2010-09-09 | Cardinal Health 207, Inc. | Automated Oxygen Delivery System |
| WO2011006184A1 (fr) | 2009-07-14 | 2011-01-20 | Resmed Ltd | Automatisation d'installation pour appareil de traitement respiratoire |
| US8924878B2 (en) | 2009-12-04 | 2014-12-30 | Covidien Lp | Display and access to settings on a ventilator graphical user interface |
| US9119925B2 (en) | 2009-12-04 | 2015-09-01 | Covidien Lp | Quick initiation of respiratory support via a ventilator user interface |
| US8335992B2 (en) | 2009-12-04 | 2012-12-18 | Nellcor Puritan Bennett Llc | Visual indication of settings changes on a ventilator graphical user interface |
| US9262588B2 (en) | 2009-12-18 | 2016-02-16 | Covidien Lp | Display of respiratory data graphs on a ventilator graphical user interface |
| US8499252B2 (en) | 2009-12-18 | 2013-07-30 | Covidien Lp | Display of respiratory data graphs on a ventilator graphical user interface |
| WO2013175345A1 (fr) | 2012-05-22 | 2013-11-28 | Koninklijke Philips N.V. | Assistance à la toux et système et procédé de mesure, ainsi qu'applications associées |
| US10362967B2 (en) | 2012-07-09 | 2019-07-30 | Covidien Lp | Systems and methods for missed breath detection and indication |
| JP6719390B2 (ja) * | 2014-06-18 | 2020-07-08 | マケット・クリティカル・ケア・アーベー | 添加ガス供給装置 |
| US9950129B2 (en) | 2014-10-27 | 2018-04-24 | Covidien Lp | Ventilation triggering using change-point detection |
| EP3359237A4 (fr) * | 2015-10-05 | 2019-06-12 | Université Laval | Procédé de distribution de gaz respiratoire à un patient, et système pour le mettre en uvre |
| US10835177B2 (en) | 2017-06-02 | 2020-11-17 | General Electric Company | Anesthesia assessment system and method for lung protective ventilation |
| CN109107007A (zh) * | 2018-07-10 | 2019-01-01 | 上海敏恒企业咨询有限公司 | 一种智能APRVplus呼吸机通气系统及使用方法 |
| KR102117158B1 (ko) * | 2018-08-21 | 2020-05-29 | 주식회사 멕 아이씨에스 | 인공 호흡기의 흡입산소농도의 자동 제어 방법 |
| US11672934B2 (en) | 2020-05-12 | 2023-06-13 | Covidien Lp | Remote ventilator adjustment |
| CN112675393B (zh) * | 2020-12-18 | 2024-04-19 | 杭州脉兴医疗科技有限公司 | 一种呼吸机撤机管理系统及方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5948106B2 (ja) * | 1980-08-27 | 1984-11-24 | 株式会社東芝 | 呼吸監視装置 |
| JPS6185963A (ja) * | 1984-10-02 | 1986-05-01 | 安本 和正 | 炭酸ガス分圧制御装置 |
| US5320093A (en) * | 1990-12-21 | 1994-06-14 | Brigham And Women's Hospital | Rapid anesthesia emergence system using closed-loop PCO2 control |
| US6463930B2 (en) * | 1995-12-08 | 2002-10-15 | James W. Biondi | System for automatically weaning a patient from a ventilator, and method thereof |
| DE50004721D1 (de) * | 1999-01-29 | 2004-01-22 | Siemens Elema Ab | Nichtinvasives verfahren zur optimierung der beatmung atelektatischer lungen |
| JP5059260B2 (ja) * | 2001-03-29 | 2012-10-24 | 帝人株式会社 | 医療機器の遠隔監視方法 |
| JP4603714B2 (ja) * | 2001-04-06 | 2010-12-22 | 帝人株式会社 | 鼻マスク式人工呼吸装置 |
| US7246618B2 (en) * | 2001-06-21 | 2007-07-24 | Nader Maher Habashi | Ventilation method and control of a ventilator based on same |
| EP2008581B1 (fr) * | 2003-08-18 | 2011-08-17 | Cardiac Pacemakers, Inc. | Systèmes et procédés de thérapie et/ou de diagnostic, et de surveillance de patient |
| DE602004028039D1 (de) * | 2003-11-26 | 2010-08-19 | Resmed Ltd | Gerät für die systemische kontrolle der atemunterstützung bei vorliegen von ateminsuffizienz |
| JP2005245825A (ja) * | 2004-03-05 | 2005-09-15 | Teijin Pharma Ltd | 呼吸用気体供給装置 |
| US7527054B2 (en) * | 2005-05-24 | 2009-05-05 | General Electric Company | Apparatus and method for controlling fraction of inspired oxygen |
| US8561611B2 (en) * | 2005-06-21 | 2013-10-22 | Ric Investments, Llc | Respiratory device measurement system |
| US20070062533A1 (en) * | 2005-09-21 | 2007-03-22 | Choncholas Gary J | Apparatus and method for identifying FRC and PEEP characteristics |
-
2008
- 2008-06-02 WO PCT/US2008/065592 patent/WO2008148134A1/fr active Application Filing
- 2008-06-02 EP EP08780743A patent/EP2167178A1/fr not_active Withdrawn
- 2008-06-02 JP JP2010510561A patent/JP5628669B2/ja active Active
- 2008-06-02 CA CA2726604A patent/CA2726604C/fr active Active
- 2008-06-02 CA CA3165969A patent/CA3165969A1/fr active Pending
-
2014
- 2014-10-02 JP JP2014203550A patent/JP6001029B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6001029B2 (ja) | 換気のための人口呼吸器の装置およびシステム | |
| US20190381264A1 (en) | Ventilator Apparatus and System of Ventilation | |
| JP2015037579A5 (fr) | ||
| US20190255268A1 (en) | Use of multiple spontaneous breath types to promote patient ventilator synchrony | |
| US11247009B2 (en) | Anomaly detection device and method for respiratory mechanics parameter estimation | |
| US9089657B2 (en) | Methods and systems for gating user initiated increases in oxygen concentration during ventilation | |
| US20130025597A1 (en) | Methods and systems for monitoring a ventilated patient with an oximeter | |
| US20150090258A1 (en) | Ventilator-initiated prompt or setting regarding detection of asynchrony during ventilation | |
| US20130053717A1 (en) | Automatic ventilator challenge to induce spontaneous breathing efforts | |
| AU2021203928B2 (en) | Patient specific auto-flowrate control | |
| US20140261424A1 (en) | Methods and systems for phase shifted pressure ventilation | |
| CN112996434B (zh) | 一种容量反应性评估方法和医疗设备 | |
| US11547784B2 (en) | System for CO2 removal | |
| US20220401676A1 (en) | Flow therapy system and method | |
| KR20230051487A (ko) | 호흡 보조와 관련된 개선 사항 | |
| US11925757B2 (en) | Ventilator | |
| WO2023094966A1 (fr) | Mesure de dioxyde de carbone de fin d'expiration pendant une oxygénothérapie à haut débit | |
| Lizza et al. | 680: RISK FACTORS FOR DEATH FROM VENTILATOR-ASSOCIATED PNEUMONIA IN THE UNITED STATES FROM 2008–2011 | |
| Arnal et al. | Mechanical Ventilation | |
| Banner et al. | 681: NONINVASIVELY DETERMINED WORK OF BREATHING DURING NONINVASIVE PRESSURE SUPPORT: VALIDATION STUDY | |
| Dubick et al. | 683: Tissue Inflammation in Awake Sheep Subjected to Extracorporeal Acid Load Co2 Removal (ALCO2R) | |
| Ventilation | Special Ventilation Techniques I: Patient-Triggered Ventilation |